Vascular endothelial growth factor in prostate cancer

被引：5

作者：

Turner, K ^{[1
]}

Jones, A ^{[1
]}

机构：

[1] Churchill Hosp, Dept Urol, Oxford OX3 7JL, England

来源：

UROLOGY | 2000年 / 56卷 / 01期

关键词：

D O I：

10.1016/S0090-4295(00)00564-1

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：183 / 183

页数：1

共 3 条

[1] Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer [J].

Duque, JLF ;

Loughlin, KR ;

Adam, RM ;

Kantoff, PW ;

Zurakowski, D ;

Freeman, MR .

UROLOGY, 1999, 54 (03) :523-527

[2] Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer [J].

Jones, A ;

Fujiyama, C ;

Turner, K ;

Fuggle, S ;

Cranston, D ;

Bicknell, R ;

Harris, AL .

BJU INTERNATIONAL, 2000, 85 (03) :276-280

[3] Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers:: A key to study an angiogenic marker in vivo? [J].

Wynendaele, W ;

Derua, R ;

Hoylaerts, MF ;

Pawinski, A ;

Waelkens, E ;

de Bruijn, EA ;

Paridaens, R ;

Merlevede, W ;

van Oosterom, AT .

ANNALS OF ONCOLOGY, 1999, 10 (08) :965-971

← 1 →